|
Volumn 17, Issue 10, 2009, Pages 759-764
|
[Induction of necrosis in the hepatocellular carcinoma HepG2 xenografts treated with SOM230].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
PASIREOTIDE;
SOMATOSTATIN;
SOMATOSTATIN RECEPTOR;
VASCULOTROPIN A;
ANIMAL;
ARTICLE;
BAGG ALBINO MOUSE;
CANCER TRANSPLANTATION;
CELL PROLIFERATION;
CELL STRAIN HEPG2;
DISEASE MODEL;
DRUG EFFECT;
DRUG SCREENING;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LIVER CELL CARCINOMA;
LIVER TUMOR;
MALE;
METABOLISM;
MOUSE;
NUDE MOUSE;
PATHOLOGY;
RANDOMIZATION;
SUBCUTANEOUS DRUG ADMINISTRATION;
VASCULARIZATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CARCINOMA, HEPATOCELLULAR;
CELL PROLIFERATION;
DISEASE MODELS, ANIMAL;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HEP G2 CELLS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
INJECTIONS, SUBCUTANEOUS;
LIVER NEOPLASMS;
MALE;
MICE;
MICE, INBRED BALB C;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
RANDOM ALLOCATION;
RECEPTORS, SOMATOSTATIN;
SOMATOSTATIN;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
EID: 79951980619
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|